Browsing publications by Dr Lindi Chen

Newcastle AuthorsTitleYearFull text
Dr Lindi Chen
Angharad Humphreys
Dr Lisa Turnbull
Dr Nicholas Bown
Professor Deborah Tweddle
et al.
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse2016
Angharad Humphreys
Dr Alem Gabriel
Dr Nicholas Bown
Dr Lindi Chen
Dr David Jamieson
et al.
Imaging flow-cytometer based detection of ALK and MDM2 amplification in neuroblastoma cell lines2016
Dr Lindi Chen
Professor Herbie Newell
Professor John Lunec
Professor Deborah Tweddle
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma2015
Laura Evans
Dr Lindi Chen
Dr Elaine Willmore
Professor Herbie Newell
Professor Deborah Tweddle
et al.
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma2015
Dr Lindi Chen
Meeting report: 3rd Neuroblastoma Research Symposium, Liverpool, 6-7th November, 20132014
Dr Lindi Chen
Dr Yan Zhao
Dr Gail Halliday
Philip Berry
Professor Herbie Newell
et al.
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma2014
Dr Lindi Chen
Professor Deborah Tweddle
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance2012
Dr Emma Bell
Dr Lindi Chen
Professor John Lunec
Professor Deborah Tweddle
MYCN oncoprotein targets and their therapeutic potential2010
Dr Lindi Chen
Professor John Lunec
Professor Deborah Tweddle
p53 is a direct transcriptional target of MYCN in neuroblastoma2010
Dr Lindi Chen
Professor Archibald Malcolm
Dr Katrina Wood
Mike Cole
Professor Andrew Pearson
et al.
p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma2007